Inclusion and exclusion criteria
male/female
The trial included male/female patients aged ≥ 18 years with histologically/cytologically confirmed metastatic or unresectable Key exclusion criteria were: evidence of small cell or small cell plus non-small cell histology; previous documentation of Patients provided voluntary written informed consent before participating in any study procedures.